Journal article
Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration
Abstract
Authors
Ravi P; Pond GR; Diamantopoulos LN; Su C; Alva A; Jain RK; Skelton WP; Gupta S; Tward JD; Olson KM
Journal
BJU International, Vol. 128, No. 5, pp. 607–614
Publisher
Wiley
Publication Date
November 1, 2021
DOI
10.1111/bju.15434
ISSN
1464-4096
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCisplatinCystectomyDeoxycytidineDoxorubicinFemaleHumansInternationalityKaplan-Meier EstimateMaleMethotrexateMiddle AgedMuscle, SmoothNeoadjuvant TherapyNeoplasm InvasivenessNeoplasm MetastasisNeoplasm Recurrence, LocalNeoplasm StagingProportional Hazards ModelsRisk FactorsTime FactorsUrinary BladderUrinary Bladder NeoplasmsVinblastineGemcitabine